EP PerMed Newsletter 14 | 26 November 2025

Dear subscribers,

we are pleased to announce the third EP PerMed Joint Transnational Call 2026. Focusing on cardiovascular, metabolic and kidney diseases, the call opened on 25 November 2025, the day before our ICPerMed & EP PerMed Joint Conference, happening now in Prague. After a short registration, a live stream is available via the EP PerMed website, and the recordings will be published shortly after the event.

The EP PerMed Consortium

EP PerMed News

26 November 2025

Ten Years implementing Personalised Medicine – first joint ICPerMed and EP PerMed Conference in Prague

The European Partnership for Personalised Medicine (EP PerMed) and the International Consortium for Personalised Medicine (ICPerMed) jointly organised a conference on the achievements in personalised medicine in the last decade on 26 and 27 November 2025 in Prague, Czech Republic. The conference brought together more than 100 international experts and stakeholders in the field to celebrate the tenth anniversary of the EU Council Conclusions on Personalised Medicine for Patients and the first Strategic Research and Innovation Agenda on Personalised Medicine.

25 November 2025

Call Announcement: JTC2026 - Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)

With the JTC2026, EP PerMed will fund research projects in human health on innovative personalised medicine strategies for patients with cardiovascular, metabolic or kidney diseases. Research projects may focus on a single disease or explore these conditions in combination. The available budget for this call is 38 Mio. € (approx.). Deadline for pre-proposal submission in 10 February 2026.

25 November 2025

EP PerMed Extended General Assembly Meeting in Prague

The EP PerMed Extended General Assembly (ExtGeA), consisting of the EP PerMed partners and ICPerMed members, met in Prague on 25 November 2025 to discuss synergies, cooperation opportunities and the work programmes of the two initiatives.

24 November 2025

Pre-Announcement: EP PerMed Fast Track 2026

EP PerMed will launch the second "Fast Track" Programme 2026 on 2 December 2025, offering targeted support to accelerate the validation and adoption of innovative personalised medicine solutions. The programme helps early-stage innovations progress by at least one Technology Readiness Level through dedicated validation studies carried out together with specialised European validation centres.

24 November 2025

Pre-Announcement: Twinning Call 2026

EP PerMed will launch its first "Twinning Call" 2026 for proposals on “Advancing Collaborative Implementation of Personalised Medicine Approaches in Healthcare” on 10 December 2025. EP PerMed "Twinning Calls" are designed to support the the implementation of personalised medicine solutions or approaches from one local setting to another one in a different country through peer-to-peer exchanges in a defined timeline.

21 November 2025

New Podcast Episode about how Joe was cured of a Genetic Disease

Joe is a lively and joyful teenager from northern England. He loves Italy because it was here that he was cured of a genetic disease called metachromatic leukodystrophy (MLD), the same disease that claimed the life of his little sister, Connie. In this episode, we follow Joe and his family’s story to explore the frontiers of personalised genetic therapy.

20 November 2025

EP PerMed RITC2026 Matchmaking Event

The matchmaking event for the RITC2026 Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (MultiPMData2026) on 18 November 2025 gathered 116 participants from diverse disciplines. During the day, 27 research ideas were presented in form of short 3 minutes pitches. Two keynote lectures introduced call relevant topics.

17 November 2025

Publications added to the EP PerMed Project Database

The EP PerMed project database features now 146 transnational research and innovation projects in personalised medicine that have been funded by EP PerMed and its predecessor, ERA PerMed. Lists of publications have now been added to the project detail pages.

12 November 2025

French National PRecISion Medicine Center in Oncology (IHU PRISM)

EP PerMed awardes the title of “Best Practice” (BP) in Personalised Medicine to the Institut Hospitalo Universitaire PRISM, National PRecISion Medicine Center in Oncology (PRISM) in France. IHU PRISM is a large, multidisciplinary national institute, dedicated to the advancement and implementation of precision oncology across various types of cancer. Its structure integrates clinical trials, molecular profiling, data science, and experimental biology, specifically designed for a comprehensive patient centric approach.

11 November 2025

New Episodes! Season 2 of the EP PerMed Podcast ‘ The Science of You’ starting

The second season of The Science of You explores personalised medicine and its advancements from a different perspective. At the heart of the narrative are the first-hand accounts of patients, family members and carers who have encountered personalised medicine approaches.

Tamara is a German nurse who has lived in Lisbon for more than twenty years. Cancer has been a recurring presence in her family, affecting three people on her father’s side as well as her mother. This episode tells her story and how a chance encounter with a young patient prompts her to undergo genetic testing, perhaps saving her life and leading her to choose preventive surgery.

11 November 2025

ESR1 Testing via Liquid Biopsy in Metastatic Breast Cancer

EP PerMed awards the title of “Best Practice” (BP) in Personalised Medicine to Cancer Patients Europe (CPE) and Italian patient associations through the development of a white paper on ESR1 mutations and the use of liquid biopsy in metastatic breast cancer. This effort stands as an excellent example of how patient advocacy can inform and accelerate implementation of personalised medicine tools, support health technology assessment processes, and ultimately improve outcomes for patients.

07 November 2025

EP PerMed at the 5th African Health Research and Innovation Funders Forum (AHRIFF)

Around 70 representatives of grant-making institutions, African government and public funding agencies, philanthropic organisations, development finance institutions and regional banks came together at the 5th AHRIFF meeting in Cape Town, South Africa, from 5-7 November. The aim was to create greater alignment between funding agencies investing in Africa and improve understanding of Africa’s health priorities.

07 November 2025

Regional Healthcare Information Platform in Halland, Sweden

EP PerMed has recently awarded the title of “Best Practice” (BP) in Personalised Medicine to the Regional Healthcare Information Platform in Halland, Sweden. As an integrated healthcare system, Region Halland has committed to fact-based provision, development and research supported by the wealth of data continuously generated in digitalised healthcare. For more than a decade, Region Halland has built information driven care where data science expertise has been added to traditional healthcare competences.

Other PM-related News

21 November 2025

THCS JTC2026 – Access to Care

THCS launches its fourth Joint Transnational Call (JTC) for proposals aiming to fund research and innovation projects that contribute to ensuring equitable access to and utilisation of health and care services and provide policy and decision makers with the knowledge and tools needed to implement resource reallocation as the health and care system transitions to address new and ongoing challenges.

20 November 2025

The Role and Impact of Pharmacogenomics in Advancing Personalised Medicine in Iran

A new pharmacogenomics initiative in Iran provides population-specific data for 168 clinically relevant drugs. By characterising allele frequencies across 37 genes, it aims to reduce adverse drug reactions and optimise treatments in oncology, cardiology and psychiatry. The project, led by the Endocrinology and Metabolism Research Institute in Tehran University of Medical Sciences, aligns with CPIC standards for clinical implementation.

18 November 2025

International Personalised Medicine Perspectives

In the frame of the ICPerMed Strategic Working Group on Internationalisation, a webinar was organised on 20 November 2025 from 15:00-16:30 CET. Dr. Emmanouil (Manolis) Dermitzakis introduced the Qatar Precision Health Institute. A recording is now available.

See all news